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Human thyrocytes were found to synthesize and secrete the
selenoenzyme extracellular glutathione peroxidase (E-GPX), a
process which was controlled by the Ca2+/phosphoinositol
second-messenger cascade. The potential involvement of thy-
INTRODUCTION
The human thyroid gland contains higher concentrations of
selenium (Se) than the liver and other human organs [1]. In
conditions of Se deficiency induced either in vivo by dietary
manipulation [2] or in vitro by using Se-deficient culture medium,
thyrocytes are able to retain the trace element by an energy-
dependent process [3,4]. These observations suggest that Se has
a number of crucial roles within the thyroid gland.
Many of the functions of Se are exerted through the expression
of specific selenoenzymes. Labelling of thyroid tissue both in vivo
[2] and in vitro [5] with [75Se]selenite has demonstrated that at
least ten selenoproteins are expressed by the gland. Whilst most
of these selenoproteins remain to be characterized, two seleno-
enzymes, type I iodothyronine deiodinase (IDI) and cytoplasmic
glutathione peroxidase (Cy-GPX), are considered to have im-
portant roles within the thyroid. IDI catalyses 5'-mono-
deiodination of the prohormone thyroxine (T4) to produce the
metabolically active tri-iodothyronine (T3) and in some species,
including man, the enzyme may provide an important source of
thyroidal T3 [6]. It has also been suggested that intracellular
glutathione peroxidase (GPX) protects the thyroid from H202-
induced peroxidative damage [7].
The thyroid synthesizes H202 at the apical membrane of the
thyrocyte, and the H202 is then utilized by thyroperoxidase (a
non-selenoenzyme) for the oxidation of iodide and subsequent
incorporation of iodine into the tyrosine residues on thyro-
globulin situated in the colloid of the follicular lumen. In the
presence of an adequate iodine supply, H202 production is
thought to be the rate-limiting step in thyroid-hormone synthesis
[7-11]. Control of H202 generation is exerted by both the cyclic
AMP and Ca2+/phosphoinositol signalling cascades, with the
latter appearing to be the most important stimulator [7-11].
Excessive concentrations of H202 are harmful to the thyrocyte,
and the GPX and catalase enzyme systems may act within the
gland to prevent the accumulation of toxic levels. It has been
roidal E-GPX in the regulation of thyroid-hormone synthesis
and in the protection of the thyrocyte from peroxidative damage
is discussed.
suggested that the thyroid atrophy found in myxoedematous
cretinism may arise from prolonged combined Se and iodine
deficiency since, in this situation, H202 production is increased,
and protection from oxidative damage is lost as a consequence of
impaired GPX synthesis brought about by lack of Se [7].
Four Se-dependent GPXs have been identified. Each has a
single selenocysteine residue encoded by a TGA triplet, but each
is expressed by a different gene and is immunochemically distinct.
Three of these GPXs are intracellular and one is extracellular.
The three intracellular enzymes are the ubiquitous cytoplasmic
GPX (Cy-GPX), a membrane-associated GPX which can
metabolize phospholipid hydroperoxides (PH-GPX) and gas-
trointestinal GPX, an enzyme expressed only in liver and intestine
(for reviews, see [12-14]).
A single extracellular GPX (E-GPX) has been identified and
purified from plasma [12,15-17]. Plasma GPX comprises four
identical subunits each having a molecular mass ofapproximately
24 kDa and is functionally, immunologically and structurally
different from Cy-GPX and the other Se-dependent peroxidases
[12]. Extracellular thioredoxin, glutaredoxin and thioredoxin
reductase can act as reductants for plasma GPX in addition to
GSH [18]. In the rat and man the major source of plasma GPX
is the renal proximal tubules [19]. Although it has been suggested
that plasma GPX may have an antioxidant role in plasma,
another possibility is that the enzyme acts in the extracellular
space of the tissues which secrete the enzyme; the enzyme has
thus been named more appropriately as 'extracellular glutathione
peroxidase' (E-GPX) [12]. The tissues identified as secretors of
E-GPX are kidney, placenta and bronchio-epithelial tissue
[12,19-23]. These tissues are under high degrees of oxidative
stress and thus may require protection from injury caused by
peroxide and oxygen-radical formation. Certain cultured trans-
formed cells of kidney and lung origin also secrete the enzyme
[21-23].
In the present paper we report that human thyrocytes grown
in primary culture synthesize and secrete E-GPX into the culture
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medium. Results are also presented to show that this process is
under hormonal control, being negatively regulated by the
Ca2+/phosphoinositol signalling pathway.
EXPERIMENTAL
Materials
Dulbecco's modified Eagle's medium (DMEM), Earle's balanced
salt solution (EBS), penicillin, streptomycin, amphotericin B and
glutamine were all obtained from ICN Flow (Costa Mesa, CA,
U.S.A.). Collagenase was purchased from Worthington Bio-
chemicals Corporation via Lorne Laboratories (Twyford, Berks.,
U.K.), and dispase supplied by Boehringer Mannheim U.K.
(Lewes, East Sussex, U.K.). [75Se]selenite was obtained from the
University of Missouri (Columbia, MO, U.S.A.). All other
reagents, including control processed serum replacement 1
(CPSR-1), were supplied by Sigma Chemical Co. (Poole, Dorset,
U.K.).
Isolation and culture of human thyrocytes
Human thyrocytes were isolated from thyroid tissue (surplus to
routine histopathological examination) from patients with func-
tional nodules undergoing thyroid surgery. Cells were isolated
using a modified version of a dog thyroid cell culture method [24]
as previously described [25]. Briefly, the tissue was finely minced
with scissors and the resulting fragments washed four times with
EBS before digestion for 2 h in 50 ml of an enzyme cocktail
containing dispase (0.5 %, w/v), trypsin (0.25 %, w/v),
collagenase (0.1 %, w/v) and BSA (2 %, w/v) in EBS. Following
digestion, an equal volume of EBS was added and the mixture
filtered through a 100 um-mesh gauze to remove undigested
tissue. The resulting filtrate, containing released thyroid cells,
was centrifuged at 450 g for 15 min to pellet the thyrocytes. The
pellet was washed twice with EBS and the cells finally resuspended
in 50 ml of DMEM containing 10% (v/v) CPSR-1 (fetal-calf
serum treated to remove immunoglobulins and endotoxins),
penicillin (100 units/ml), streptomycin (100 ,ug/ml), ampho-
tericin B (2.5 ,ug/ml) and glutamine (2 mM). The cell suspension
was then filtered through a 30,m-mesh gauze and the cell yield
measured with a modified Neubauer haemocytometer. Finally
the thyrocytes were plated out in DMEM/10% CPSR-1 into
75 cm2 flasks in 25 ml of medium at a density of 107 cells/flask
and incubated at 37 °C in an atmosphere of 5 % CO2.
After an overnight incubation, the culture medium was re-
moved, the cells washed twice with EBS and fresh culture
medium added. The thyrocytes were then grown for a further 2
days, after which time they had achieved confluence. The cells
were then washed with EBS and cultured for a further 72 h with
DMEM (with no CPSR-1) in the presence of 0.02 MBq/ml
[75Se]selenite. Mimics of the cyclic AMP and Ca2+/
phosphoinositol second-messenger cascades and the isoprenoid
fungal metabolite Brefeldin A (a compound which blocks in-
tracellular transport of secretory proteins and thus prevents their
export) were also added to the culture medium for the final 72 h
incubation at the specified concentrations. After this 72 h period
the culture medium was removed, centrifuged at 3000 g for
20 min and dialysed over 2 days against 2 litres of 60 mmol/l Tris
buffer, pH 7.8, containing 1 mM dithiothreitol and 1 mM EDTA,
with four changes of buffer being used over the dialysis period.
This dialysis step was included to remove the majority of the
unbound [75Se]selenite. The dialysed medium was then concen-
trated to 2.5 ml by placing the dialysis sack in a saturated
poly(ethylene glycol) solution prepared in the dialysis buffer.
Also after this 72 h period the cultured thyrocytes were washed
twice with EBS, harvested into 25 ml of EBS by scraping,
followed by centrifugation at 2000 g for 10 min. The thyrocytes
were resuspended in 1 ml of dialysis buffer and sonicated.
Identfflcation of extracellular and intracellular [75Se]selenoprotelns
After dilution to a common final protein concentration, the
samples of concentrated culture medium and sonicated thyro-
cytes were diluted 2: 1 with 'boiling mix' (SDS, 35 mM; glycerol,
1.4 mM; 2-mercaptoethanol, 0.3 mM; Bromophenol Blue,
15 mM) and heat-treated at 90 °C for 10 min. The [75Se]seleno-
proteins were separated by SDS/PAGE on a 12% gel; the
resulting gel was dried and the selenoproteins revealed by
autoradiography using Kodak X-OMAT XAR-5 film.
Immunoprecdpitation of GPX In growth medium
Rabbit antisera (20 ,ul) raised to E-GPX [26] or Cy-GPX were
added to concentrates of 75Se-labelled dialysed culture medium
(200 1l) and were incubated overnight at 4°C; non-immune
rabbit serum was also used as a control. Pre-precipitated donkey
anti-rabbit antiserum (DARS) was then added (50 1,) to each
incubation and shaken at room temperature for 4 h. The DARS
was then sedimented by centrifugation at 3000 g for 15 min and
the pellet washed with EBS and then taken up in boiling mix. The
immunoprecipitated selenoproteins were identified as described
above.
Effect of Brefeldin A, thyrotropin and different second-messenger
systems on extra-cellular and Intra-cellular ['5Se]selenoprotein
expression
The effects of the various test compounds on the [75Se]seleno-
protein content of the culture medium were investigated by
adding these compounds at specified concentrations for the last
72 h of culture. These compounds were: Brefeldin A (5 ug/1),
thyrotropin (TSH, 1.0 units/litre), 8-bromoadenosine 3': 5'-cyclic
monophosphate (8-bromo cAMP, 10-4 M), the phorbol ester,
phorbol 12-myristate 13-acetate (PMA, 10-6 M) and the calcium
ionophore A23187 (10-6 M).
GPX activity in culture media
For these experiments thyrocytes were cultured as described
above but in the absence of [75Se]selenite. Three control flasks
plus three flasks containing A23 187 (10-6 M) were used. After the
final 72 h period the culture media were concentrated as described
above and the activity ofGPX in the concentrates was determined
as described previously using H202 as substrate [27]. Results
were expressed as units/litre+ S.D. in the concentrated culture
medium. GPX activity was also determined in the concentrated
medium after the addition of iodoacetic acid 2 x 10-3 M and
100 x 10-6 M gold thioglucose, both known inhibitors of Se-
dependent GPX.
Determination of protein
The protein content of sonicated thyrocytes and culture medium
was determined using the Bradford dye-binding method [28],
adapted for use on a Cobas Fara centrifugal analyser (Roche
Diagnostics, Welwyn Garden City, U.K.).
RESULTS
Expression of [75Se]selenoprotelns in thyrocytes and culture
medium
At least 11 intracellular proteins were labelled in thyrocytes
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Figure 1 Autoradlograph of an SOS/PAGE gel of sonicated thyrocytes
Thyrocytes were obtained as follows: lane 1, thyrocytes grown in the presence of 0.02 MBq/ml
[75Se]selenite; lane 2, thyrocytes grown in the presence of 0.02 MBq/ml [75Se]selenite with
1 units/mI TSH. Nofe the induction by TSH of the 28.1 kDa I0I band (25 1ug of protein was
loaded on each lane)
grown in the presence of [75Se]selenite, as revealed from the
autoradiograph of the SDS/PAGE gels (Figure 1). Within the
thyrocytes, labelled selenoproteins with a molecular mass of
approx. 24kDa comprised less than 10% of the total seleno-
proteins expressed by the cells.
In the culture medium two poorly separated selenoprotein
bands were found, the band with the lower molecular mass being
the most intense and having a mean molecular mass, calculated
from four experiments, of24+ 1.6 kDa. These two selenoproteins
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Figure 2 Autoradiograph of an SDS/PAGE gel of concentrated culture
media obtained from two different thyrocyte cultures (a and b)
Lane 1, medium from thyrocyte culture (a) grown in the presence of 0.02 MBq/ml
[75Se]selenite.; lane 2, medium from thyrocyte culture (a) treated with Brefeldin A (5 ,ug/ml);
lane 3, medium from thyrocyte culture (b); lane 4 medium from thyrocyte culture (b) treated
with Brefeldin A (5 ,ug/ml) (10 ,ug of protein was loaded on each lane).
Molecular
mass
1 2 3 (kDa)
31.0
21.5
R, Si!;
Figure 3 Autoradlograph of an SOS/PAGE gel of 7'Se-labelled proteins
Immunoprecipitated from culture medium by: non-immune rabbit serum
(lane 1), E-GPX antibody (lane 2) and Cy-GPX antibody (lane 3)
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Figure 4 Autoradlograph of an SOS/PAGE gel of sonicated thyrocytes that
had been treated with various agents in the presence of 0.02 MBq/ml
[75Se]selenite
Lane 1, no additions; lane 2, Brefeldin A (5 ug/ml); lane 3, Calcium ionophore A23187
(1 0-6 M) (25,g of protein was loaded on each lane).
accounted for more than 95% of the total 75Se-labelled proteins
(Figure 2, lanes 1 and 3). Antisera to E-GPX, but not Cy-GPX
or non-immune rabbit serum, immunoprecipitated the 24 kDa
selenoprotein band (Figure 3).
Effect of Brefeldin A, thyrotropin and second messenger systems
on the secretion and intracellular accumulation of E-GPX
Inclusion of Brefeldin A into the culture medium prevented the
appearance of E-GPX in the culture medium (Figure 2, lanes 2
and 4), but the amount of enzyme within the thyrocytes (as
judged from the intensity of the 24 kDa band) appeared to be
increased (Figure 4, lane 2). Treatment with Brefeldin A also
produced an increase in the amount of a 14.4 kDa selenoprotein
within the thyrocytes (Figure 4, lane 2), but no similar seleno-
protein was identified in the culture medium; no further charac-
terization of this intracellular selenoprotein was performed.
The calcium ionophore A23187 diminished the amount of
E-GPX secreted into the culture medium to levels which were less
that 10% of control values (Figure 5, lane 3). Whilst PMA had
little or no effect on the amount of the E-GPX in the medium
when added alone (Figure 5, lane 2), it augmented the effect of
A23 187 when added in conjunction with this compound (Figure
5, lane 4). The addition of PMA with A23187 produced an
increase in the intensity of the intracellular 24 kDa band similar
to the effect seen with Brefeldin A (Figure 4, lanes 2 and 3).
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Figure 5 Autoradlograph of an SDS/PAGE gel of concentrated culture
media obtained from thyrocytes treated with various agents in the presence
of 0.02 MBq/ml [75Se]selenite
Lane 1, no additions; lane 2, PMA (10-6 M); lane 3, calcium ionophore A23187 (10-6 M);
lane 4, PMA (10-6 M) with calcium ionophore A23187 (10-6 M); lane 5, 8-bromo cAMP
(1 0-4 M) (25 ,ig of protein was loaded on each lane).
Addition of 8-bromo cAMP had no significant effect on the
extracellular (Figure 5, lane 5) or intracellular accumulation of
E-GPX. Similarly TSH, when added at 1 U/L, had no effect on
the intracellular or extracellular amounts of E-GPX (results not
shown).
Effect of calcium ionophore with phorbol ester on GPX enzymic
activity in culture medium
The addition of A23187 to the culture medium resulted in a
significant decrease (P < 0.05) in GPX activity from 41 + 7
units/litre in culture media obtained from untreated cells to
25 + 4 units/litre in cells treated with A23187, as determined
from triplicate incubations. lodoacetic acid and gold thioglucose
added to the assay buffer completely inhibited GPX activity.
DISCUSSION
Human thyrocytes grown in primary culture secrete predomi-
nantly a selenoprotein which has a molecular mass on SDS/
PAGE of 24 kDa. Secretion of this protein was prevented by
Brefeldin A, and the selenoprotein profile in the growth media
was quite different to the profile observed in the cell lysates,
indicating that the 24 kDa protein did not arise from non-specific
leakage of protein from thyrocytes. GPX activity was found in
the culture medium of control cells and could be inhibited by the
addition of iodoacetic acid and gold thioglucose, known
inhibitors of Se-dependent GPX activity. GPX activity was also
diminished in the culture medium of thyrocytes exposed to
A23187, a treatment which also decreased the expression of the
24 kDa selenoprotein. The 24 kDa selenoprotein could be
immunoprecipitated with antiserum raised to E-GPX, but not
with antiserum raised to Cy-GPX or with non-immune serum.
Cy-GPX and E-GPX are both tetrameric with a subunit mol-
ecular mass of approx. 24 kDa, but these enzymes are
functionally, chemically and immunochemically distinct, the
latter being exported from the cell after synthesis. Our obser-
vations are thus consistent with thyrocytes synthesizing and
secreting E-GPX into the growth media. In many experiments a
double selenoprotein band on SDS/PAGE was observed. This
phenomenon may be the result of proteolysis of E-GPX after
release into the culture medium or differences in disulphide
bridges. This phenomenon of multiple bands has been described
previously for Cy-GPX [19,29].
Previously E-GPX production from 'normal' human tissue
has been reported only in renal, lung and placental tissue
[19,20,23], and current evidence would indicate that the E-GPX
circulating in human plasma arises mainly from kidney [19]. In
anephric patients the activity ofE-GPX in plasma is decreased to
23 % of the values found in plasma from matched controls and,
similarly, in nephrectomized rats the E-GPX in plasma is reduced
to 300% of control values [19]. These observations suggest that
non-renal tissue may provide up to 30% of circulating E-GPX,
and the possibility arises that the thyroid may provide a
significant contribution to this non-renal source of plasma E-
GPX.
What is the function of E-GPX in the thyroid? Our data
suggest that E-GPX may provide an important mechanism for
the regulation of thyroid-hormone synthesis. Availability of
thyroidal H202 in the follicular lumen represents the rate-limiting
step in thyroid-hormone synthesis [8-11]. Production of H202 is
stimulated through the Ca2+/phosphoinositol cascade [8-111
and, in vitro, the addition of Ca2+ ionophores such as A23187
produces a marked stimulation in H202 production [9-11].
Phorbol ester (e.g. PMA) has a similar, though smaller, stimu-
latory effect on H202 production [10,11], but phorbol esters
augment the stimulatory effect of calcium ionophore [10]. In the
present study we have shown that E-GPX secretion by the
thyrocyte is diminished considerably by the second-messenger
systems which promote H202 synthesis, and this is also ac-
companied by a loss in GPX activity against H202 in the culture
medium. Thus when increased thyroid-hormone synthesis is
signalled by the Ca2+/phosphoinositol pathway, this would lead
to both an increase in H202 generation on the luminal side of the
apical membrane of the thyrocyte and a reduction in H202
degradation within the follicular lumen. These concurrent
changes would amplify the increase in H202concentration within
the follicular lumen during stimulation ofhormone synthesis and
thus potentiate the availability of this rate-limiting compound
for thyroid hormone synthesis. When thyroid-hormone synthesis
is not signalled, hormone production would be prevented both
by diminished H202 production and by E-GPX secretion, which
would degrade any H202 released into the lumen in the basal
state.
E-GPX may have a role in protecting the colloid from
peroxidative damage in the basal state but, as a protective agent,
its site of action is more likely to be intracellular. We have shown
that activation of the Ca2+/phosphoinositol signalling cascade
leads to an accumulation of E-GPX within the thyrocyte, where
it could act, along with Cy-GPX, PH-GPX and catalase, to
prevent intracellular peroxidative damage from any H202 which
may diffuse into the cell from the follicular lumen, particularly
during stimulation of thyroid-hormone synthesis when H202
production will be greatest. Similarly, intracellular GPX may
also protect the thyrocyte from the accumulation of harmful
lipid hydroperoxides.
In conclusion, human thyrocytes synthesize and secrete E-
GPX, a process which can be controlled by the Ca2+/
phosphoinositol signalling cascade. Evidence suggests that the
primary role of the enzyme may be in modulating a supply of
H202 for thyroid-hormone synthesis rather than exerting a
protective effect on the colloid against possible peroxidative
cellular damage. However, translocation of E-GPX from the
extracellular to the intracellular space may provide an important
mechanism to allow a rapid adaptation to prevent peroxidative
damage from diffusion of extracellular H202 during stimulation
of thyroid-hormone synthesis.
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